IRIS UniCatt

Siciliano, Massimo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.982
EU - Europa 2.460
AS - Asia 2.183
SA - Sud America 365
AF - Africa 38
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 4
Totale 8.041
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.918
SG - Singapore 1.109
DE - Germania 1.003
CN - Cina 499
SE - Svezia 416
BR - Brasile 313
IT - Italia 209
UA - Ucraina 208
FR - Francia 173
VN - Vietnam 166
GB - Regno Unito 115
IE - Irlanda 103
FI - Finlandia 80
IN - India 65
ID - Indonesia 64
TR - Turchia 50
RU - Federazione Russa 42
JP - Giappone 40
HK - Hong Kong 37
BD - Bangladesh 36
CA - Canada 36
IQ - Iraq 24
BE - Belgio 23
AR - Argentina 22
IR - Iran 21
PL - Polonia 20
MX - Messico 18
CI - Costa d'Avorio 13
NL - Olanda 13
AE - Emirati Arabi Uniti 9
AT - Austria 9
PK - Pakistan 9
SA - Arabia Saudita 9
EC - Ecuador 8
EU - Europa 8
LT - Lituania 8
ZA - Sudafrica 7
AZ - Azerbaigian 6
MA - Marocco 6
UZ - Uzbekistan 6
VE - Venezuela 6
GR - Grecia 5
JO - Giordania 5
RO - Romania 5
AU - Australia 4
CH - Svizzera 4
DK - Danimarca 4
BO - Bolivia 3
BY - Bielorussia 3
CL - Cile 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
EG - Egitto 3
ES - Italia 3
IL - Israele 3
KG - Kirghizistan 3
MY - Malesia 3
PE - Perù 3
PT - Portogallo 3
BH - Bahrain 2
CO - Colombia 2
ET - Etiopia 2
HN - Honduras 2
KE - Kenya 2
KR - Corea 2
KZ - Kazakistan 2
MK - Macedonia 2
NP - Nepal 2
PH - Filippine 2
PY - Paraguay 2
TN - Tunisia 2
UY - Uruguay 2
AD - Andorra 1
BG - Bulgaria 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GD - Grenada 1
GE - Georgia 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
MN - Mongolia 1
MU - Mauritius 1
NI - Nicaragua 1
OM - Oman 1
PS - Palestinian Territory 1
QA - Qatar 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SR - Suriname 1
SV - El Salvador 1
TH - Thailandia 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.041
Salva come PNG Salva come JPEG
Città #
Singapore 673
Chandler 470
Ashburn 270
San Jose 229
Jacksonville 121
Beijing 110
San Mateo 104
Dublin 102
Dallas 86
New York 82
Ann Arbor 74
The Dalles 66
Nürnberg 62
Jakarta 59
Ho Chi Minh City 58
Wilmington 58
Cattolica 57
Nanjing 57
Los Angeles 53
Lauterbourg 50
Boston 49
Munich 47
Dearborn 46
Hanoi 46
Woodbridge 39
Izmir 38
Tokyo 38
Frankfurt am Main 35
Helsinki 32
Marseille 32
Princeton 32
Redwood City 31
Hong Kong 29
Nanchang 27
Bremen 26
Houston 26
Moscow 26
Zhengzhou 25
Rome 24
Brussels 23
Lawrence 23
São Paulo 23
Santa Clara 21
Tianjin 21
Augusta 20
Hangzhou 20
Hefei 20
Buffalo 19
Lancaster 19
Leawood 19
Andover 18
Hebei 17
Seattle 16
Warsaw 16
Boardman 15
Phoenix 15
Shenyang 15
Milan 14
Abidjan 13
Changsha 13
Fairfield 13
Orem 13
Shanghai 13
Atlanta 12
Falls Church 12
Paris 12
Turku 12
Kunming 11
London 11
Stockholm 11
Amsterdam 10
Chicago 10
Norwalk 10
Toronto 10
University Park 10
Guangzhou 9
Baghdad 8
Curitiba 8
Kish 8
Las Vegas 8
Nuremberg 8
Rio de Janeiro 8
Salvador 8
Bologna 7
Brooklyn 7
Da Nang 7
Jiaxing 7
Mountain View 7
Chennai 6
Detroit 6
Dhaka 6
Goiânia 6
Haiphong 6
Jinan 6
Kent 6
Mcallen 6
Memphis 6
Montreal 6
Riyadh 6
Tashkent 6
Totale 4.211
Salva come PNG Salva come JPEG
Nome #
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 247
Etanercept therapy in two patients with psoriasis and concomitant hepatitis C 247
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 205
A pilot study of capsule endoscopy after a standard meal for the detection and grading of oesophageal varices in cirrhotic patients 203
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib 202
Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound 190
Liver transplantation in patients with alcoholic liver disease: A retrospective study 190
Model for End-stage Liver Disease Dynamic Stratification of Survival Benefit 184
Radiofrequency ablation plus drug-eluting beads transcatheter arterial chemoembolization for the treatment of single large hepatocellular carcinoma 178
Early prediction of response to Sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound 176
Contrast-enhanced ultrasound in the short-term evaluation of hepatocellular carcinoma after locoregional treatment 176
L'insufficienza epatica: algoritmi diagnostici e trattamenti medici 171
Transarterial chemoembolization with degradable starch microspheres (DSM-TACE): an alternative option for advanced HCC patients? Preliminary results 170
Incidence of upper aerodigestive tract cancer after liver transplantation for alcoholic cirrhosis: a 10-year experience in an Italian center 169
Safety of etanercept in patients with psoriasis and hepatitis C virus assessed by liver histopathology: preliminary data. 168
A 5-year prospective study of the late resolution of chronic hepatitis C after antiviral therapy 160
Microscopic colitis 160
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib 159
An update on clinical applications of hepatospecific contrast media in magnetic resonance imaging of liver parenchyma 158
HepatoCATT Study Group for the Multidisciplinary Management of HCC. Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible? 158
Noninvasive Evaluation of Clinically Significant Portal Hypertension in Patients with Liver Cirrhosis: The Role of Contrast-Enhanced Ultrasound Perfusion Imaging and Elastography 156
Orthotopic liver transplantation after successful treatment with anti-CD20 monoclonal antibody (rituximab) for severe steroid-resistant autoimmune hemolytic anemia: a case report 149
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma 148
-Prognostic value of MELD score and donor quality in liver transplantation: implications for the donor recipient match. 143
Allocation of nonstandard livers to transplant candidates with high MELD scores: Should this practice be continued? 142
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient. 141
Impact of new DAA therapy on real clinical practice: A multicenter region-wide cohort study 141
Donor risk index and organ patient index as predictors of graft survival after liver transplantation 137
Interventional oncology treatment for unresecable early stage HCC in patient with high risk for intraprocedural bleeding: is a single step combined therapy safe and feasible? 137
Model for end-stage liver disease dynamic stratification of survival benefit 136
ACE I allele is associated with more severe portal hypertension in patients with liver cirrhosis: A pilot study 136
Liver transplantation in alcoholic patients: Impact of an alcohol addiction unit within a liver transplant center 132
Treatment of chronic hepatitis C virus infection with pegylated interferon and ribavirin in cirrhotic patients awaiting liver transplantation 130
Treatment of hepatitis C in compensated cirrhotic patients is equally effective before and after liver transplantation 130
Missed linkage to care for patients who screened positive for Hepatitis C in a tertiary care centre: Results of the Telepass project 130
-Allocation of nonstandard livers to transplant candidates with high MELD scores: Should this practice be continued? 129
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 128
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network 127
ANGIOTENSIN-CONVERTING ENZYME I/D POLYMORPHISM IS ASSOCIATED WITH SIGNIFICANTLY DIFFERENT VALUES OF HEPATIC VENOUS PRESSURE GRADIENT IN PATIENTS WITH LIVER CIRRHOSIS 126
Model for End-stage Liver Disease Dynamic Stratification of Survival Benefit 122
Donor Risk Index and Organ Patient Index as Predictors of Graft Survival After Liver Transplantation 120
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 120
Effectiveness of Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir in Hemodialysis Patients With Hepatitis C Virus Infection and Advanced Liver Fibrosis: Case Reports 117
Prognostic value of MELD score and donor quality in liver transplantation: implications for the donor recipient match. 116
Regorafenib: a promising treatment for hepatocellular carcinoma 116
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient 110
Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible? 108
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient 105
Acute decompensation and absence of brain and kidney dysfunction predict long-term efficacy of plasma exchange in hyper-bilirubinemic cirrhotic patients awaiting liver transplantation 100
[Chronic hepatitis C virus infection: clinical picture and treatment possibilities] 98
Future of liver disease in the era of direct acting antivirals for the treatment of hepatitis C 94
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 86
Lack of reduction in serum alpha-fetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with hepatitis C virus-related cirrhosis 85
The new era of hepatitis C treatment: still the tip of the iceberg? 84
Donor-Recipient MELD-Based Match in a Patient Who Required Three Liver Grafts in the Era of Nonstandard Donors: Case Report 75
Late Development of Splenic Artery Aneurysm After Orthotopic Liver Transplantation: A Case Report 73
Treatment of hepatitis C in compensated cirrhotic patients is equally effective before and after liver transplantation 72
Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcome 61
Totale 8.131
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.157
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.157
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202116 0 0 0 0 0 0 0 0 0 0 0 16
2021/2022598 37 55 15 39 42 18 10 120 28 38 80 116
2022/20231.201 150 160 118 202 61 171 54 95 128 7 37 18
2023/2024470 24 150 21 32 12 83 24 6 5 21 43 49
2024/2025964 16 34 84 23 111 28 25 48 149 99 196 151
2025/20262.657 397 51 178 275 601 142 458 109 154 165 70 57
Totale 8.131